Singapore Wins Amgen State-of-the-art Manufacturing mAB Plant
This article was originally published in PharmAsia News
Executive Summary
U.S. based Amgen Inc. becomes the latest major multinational drug company to establish a manufacturing plant in Singapore, placing a bet the wealthy city state can act as a safe commercial hub in Asia and provide a skilled workforce.